Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome

被引：10
作者：
Buonuomo, Paola Sabrina [1 ]
Campana, Andrea [1 ]
Insalaco, Antonella [1 ]
Bracaglia, Claudia [1 ]
Pardeo, Manuela [1 ]
Cortis, Elisabetta [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Dept Pediat Med, Rome, Italy
来源：
RHEUMATOLOGY INTERNATIONAL | 2013年 / 33卷 / 04期
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1007/s00296-011-2319-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1097 / 1098
页数：2
相关论文
共 11 条
  • [1] Baghai M, 2001, MAYO CLIN PROC, V76, P653
  • [2] Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis
    Chan, ATY
    Cleeve, V
    Daymond, TJ
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2002, 78 (915) : 47 - 48
  • [3] Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis
    Choi, Kyoung-Hwa
    Yoo, Wan-Hee
    [J]. RHEUMATOLOGY INTERNATIONAL, 2009, 29 (04) : 463 - 466
  • [4] Clark P, 2003, CAN J SURG, V46, P9
  • [5] Macrophage activation syndrome in juvenile idiopathic arthritis
    Cortis, Elisabetta
    Insalaco, Antonella
    [J]. ACTA PAEDIATRICA, 2006, 95 : 38 - 41
  • [6] An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
    Davi, Sergio
    Consolaro, Alessandro
    Guseinova, Dinara
    Pistorio, Angela
    Ruperto, Nicolino
    Martini, Alberto
    Cron, Randy Q.
    Ravelli, Angelo
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) : 764 - 768
  • [7] Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis:: a prospective study
    Flendrie, M
    Vissers, WHPM
    Creemers, MCW
    de Jong, EMGJ
    van de Kerkhof, PCM
    van Riel, PLCM
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) : R666 - R676
  • [8] Macrophage activation syndrome: advances towards understanding pathogenesis
    Grom, Alexei A.
    Mellins, Elizabeth D.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (05) : 561 - 566
  • [9] Hsieh T, 2000, CAN MED ASSOC J, V163, P393
  • [10] Safety of tumour necrosis factor-α antagonists
    Khanna, D
    McMahon, M
    Furst, DE
    [J]. DRUG SAFETY, 2004, 27 (05) : 307 - 324
12